Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses.
about
Synthetic Peptides as Protein MimicsStatus of hepatitis C virus vaccination: Recent updateTRIM21: a cytosolic Fc receptor with broad antibody isotype specificityGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignElectrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsAdvances in structure-based vaccine designA Blueprint for HIV Vaccine DiscoveryDesigning synthetic vaccines for HIVAntibody responses to envelope glycoproteins in HIV-1 infectionAdvances in norovirus biologyGene therapy strategies for HIV/AIDS: preclinical modeling in humanized miceA global approach to HIV-1 vaccine developmentMechanisms of hemagglutinin targeted influenza virus neutralizationAAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing ActivityCo-evolution of a broadly neutralizing HIV-1 antibody and founder virusDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityStructural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic EpitopeDiverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 bindingStructural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibodyRational HIV Immunogen Design to Target Specific Germline B Cell ReceptorsA common solution to group 2 influenza virus neutralizationProof of principle for epitope-focused vaccine designAntibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope SpikeStructural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationProgress in HIV-1 vaccine development.Griffithsin: An Antiviral Lectin with Outstanding Therapeutic PotentialBroadly Neutralizing Antibodies for HIV EradicationAdult immunization-Need of the hourA hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humansMax Bergmann lecture protein epitope mimetics in the age of structural vaccinologyImmunogenicity of membrane-bound HIV-1 gp41 membrane-proximal external region (MPER) segments is dominated by residue accessibility and modulated by stereochemistry.An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infectionA Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo ModelsGlycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors.Strategies towards universal pandemic influenza vaccines.Ultrasensitive detection of influenza viruses with a glycan-based impedimetric biosensor.Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site.Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaquesHigh-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.
P2860
Q26770255-E76C240A-28E5-4CE7-9700-7AE91BF18E45Q26774612-143768AA-0941-45FD-AD7A-482E6F268636Q26779753-24841DCE-FD73-4CA7-87C5-62391AD3E4C1Q26801759-79135555-7BC6-4595-A45C-50219995441FQ26822552-0D649C77-AB2C-43FA-8886-22E66B549CF5Q26824545-73BAD786-6703-4EB3-A109-03499AEAD2E8Q26829865-F5D12C50-0B7A-4E74-9EF2-21B12741712AQ26862617-0379E516-BEF4-4A5B-88F5-B06A218D9DF6Q26991572-DBC41E63-26BD-4409-8EF2-9B7F7F9ED611Q27016152-E0007024-6E99-432F-93F0-A46615880DF8Q27022347-4CEE1A61-E696-48AA-9ED9-5E3BAE1E6935Q27024614-1E899D78-D3EB-4901-A8C2-C1AB1DC8A566Q27302234-EB035AB6-9740-478E-A744-220CBCD74476Q27318266-3F3AE726-49F5-42DF-BF81-BD552533E185Q27644501-E994485A-CCB7-482D-B1A0-4A560468DF45Q27654848-8F6C635C-FFF4-4E6D-A630-7148257636E2Q27674417-DB639723-836D-454F-9427-0880C5C15BE2Q27675486-4317841B-570E-4528-A28D-3C1E5D05DBDAQ27677011-FE9160A3-1129-47D5-BB9D-71F999CD8F74Q27677104-D47891B1-DD6C-4D25-90BC-1F1D6BE29092Q27680873-30D04043-FF00-46E5-A2CC-16D0E8D9089BQ27681593-3DB08F43-BF2D-4DD6-B794-41CE8735CF9EQ27683540-C4AA47AC-4C7F-4E00-BCF9-9F88FBFDBF46Q27683553-8DF315EB-241C-4878-B6A0-A5AA15CAFAD5Q27684578-F7B573E9-6244-471D-8C16-19FE9EB28A04Q27693849-CEE01C6F-9578-43F0-9977-020CC349586EQ27928014-945ECA27-A939-4DA2-B147-108A4A4F2906Q28073939-E3335C6E-48C4-47B9-A213-004A187EF7F1Q28077096-7F7633FF-6062-4DCC-9EAA-50F0C5A3FC18Q28488268-BC65851A-9B6A-4952-908A-399A90126B6CQ30155145-5DAACDB4-AE55-4489-81AA-6F3D0D082721Q30353709-49AD156B-3E98-4985-985A-AAD47F05CB03Q30371674-58931A36-BBCE-47AC-87DB-A64008022461Q30379545-8058EB93-ACE1-41FE-8941-8A1D1AC8A70EQ30382105-E775DD85-E6FC-425E-AE98-7598904036B4Q30382226-35B24FC8-8B2C-47D8-9C62-D731772D15F1Q30382860-53104040-6AC4-4EF1-8AEF-9C1883E185D7Q30382955-21304DB8-AD0C-4173-8412-4F8AFB83BE14Q30427950-D0299BBE-36E9-4DE0-A96D-9C9EE37DC2ACQ30570557-4C8C56F0-EB2F-4723-A267-7EDE99849ED4
P2860
Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Broadly neutralizing antibodie ...... antigenically diverse viruses.
@ast
Broadly neutralizing antibodie ...... antigenically diverse viruses.
@en
type
label
Broadly neutralizing antibodie ...... antigenically diverse viruses.
@ast
Broadly neutralizing antibodie ...... antigenically diverse viruses.
@en
prefLabel
Broadly neutralizing antibodie ...... antigenically diverse viruses.
@ast
Broadly neutralizing antibodie ...... antigenically diverse viruses.
@en
P2093
P2860
P356
P1433
P1476
Broadly neutralizing antibodie ...... antigenically diverse viruses.
@en
P2093
Dennis R Burton
Ian A Wilson
Robyn L Stanfield
P2860
P304
P356
10.1126/SCIENCE.1225416
P407
P577
2012-07-01T00:00:00Z